David Setboun's most recent trade in Brainstorm Cell Therapeutics, Inc. was a trade of 5,000 Common Stock done at an average price of $12.9 . Disclosure was reported to the exchange on July 16, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Brainstorm Cell Therapeuti... | David Setboun | EVP and COO | Purchase of securities on an exchange or from another person at price $ 12.95 per share. | 16 Jul 2020 | 5,000 | 55,000 (0%) | 0% | 12.9 | 64,740 | Common Stock |